For example, upregulation or amplification of SKIL has been associated with breast cancer [75], squamous cell carcinoma of the esophagus [76], prostate cancer, squamous cell carcinoma of the head and neck, and non-small cell lung cancer [77]. This evidence concerns the gene SKIL and esophageal squamous cell carcinoma.